BRIEF-SEED Therapeutics Completes $30 Million Series A-3 Financing
Reuters
Sep 23
BRIEF-SEED Therapeutics Completes $30 Million Series A-3 Financing
Sept 23 (Reuters) - Eisai Co Ltd 4523.T:
SEED THERAPEUTICS COMPLETES $30 MILLION SERIES A-3 FINANCING
SEED THERAPEUTICS : ANTICIPATES ENTERING FIRST-IN-HUMAN CLINICAL TRIALS OF ST-01156 IN Q1 2026
SEED THERAPEUTICS: RECEIVED $60 MILLION IN EQUITY, AND COLLABORATION UPFRONT & MILESTONE PAYMENTS COMBINED, FROM PARTNERSHIPS WITH ELI LILLY & EISAI
Source text: ID:nGNX5WPwGR
Further company coverage: 4523.T
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.